Part 2/10:
Hims and Hers is a telehealth platform focusing on various specialties, including erectile dysfunction, hair loss, and weight loss. This innovative company seeks to build long-term customer relationships through its subscription model while being independent of traditional insurance ecosystems. As a result, the company boasts lower costs and greater efficiency compared to conventional pharmacies.
Hims and Hers has reported an astounding compound annual growth rate (CAGR) of 94.9% since 2018. With over 2.1 million subscribers and a revenue forecast indicating a 90% increase in Q4 2024, this stock shows tremendous staying power as it expands its product offerings.